BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, March 26, 2026
Home » Newsletters » BioWorld MedTech

BioWorld MedTech

Oct. 21, 2013

View Archived Issues

AirXpanders reports positive full PACE-2 study results

Read More

Washington roundup: CMS unpersuaded by PILD for stenosis of lumbar spine

Read More

Court report: Boston Sci to pay $30 million to settle Guidant allegations

Read More

Patent watch: Sanuwave receives patent for extracorporeal shock device

Read More

Deals roundup: Union MedTech acquires RBL's exoskeleton tech

Read More

Agreements/contracts: United Health expands HemoStyp distribution

Read More

Grants roundup: Genalyte gains $1M SBIR grant from National Cancer Institute

Read More

HIT roundup: Telemis unveils its latest imaging software solution

Read More

Med-Tech Notes

Read More

Product Briefs

Read More

People in the News

Read More

MDD's Neurology Extra

Read More

Korean regulation updated: South Korea eases requirements for all Class I medical devices

Entering the South Korean market is now easier for makers of low-risk medical devices. The country's Ministry of Food and Drug Safety (MFDS) updated its regulations last month and dropped a number of inspection and registration requirements for all Class I devices. Korean medical devices are classified into four categories based on the risk level. Class I devices are considered low risk, There are two kinds of Class I devices, regular and specially controlled. Read More

CDx Diagnostics receives positive WATS3D results

Read More

Popular Stories

  • Today's news in brief

    BioWorld

    BioWorld briefs for March 25, 2026.

  • MRI image brain on black background

    ADPD 2026: Can we prevent dementia? Scientists quantify it

    BioWorld
    Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
  • Illustration of Alzheimer's disease in the brain

    ADPD 2026: Three inflection points to target Alzheimer’s disease

    BioWorld Science
    A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
  • Art concept for Parkinson's disease

    Emerging therapeutic strategies for Parkinson’s at ADPD 2026

    BioWorld
    Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 24, 2026
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing